You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 24, 2024

EDEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Edex patents expire, and what generic alternatives are available?

Edex is a drug marketed by Endo Operations and is included in one NDA.

The generic ingredient in EDEX is alprostadil. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the alprostadil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Edex

A generic version of EDEX was approved as alprostadil by HIKMA on January 20th, 1998.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for EDEX?
  • What are the global sales for EDEX?
  • What is Average Wholesale Price for EDEX?
Summary for EDEX
Drug patent expirations by year for EDEX
Drug Prices for EDEX

See drug prices for EDEX

US Patents and Regulatory Information for EDEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Operations EDEX alprostadil INJECTABLE;INJECTION 020649-001 Jun 12, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations EDEX alprostadil INJECTABLE;INJECTION 020649-007 Jul 30, 1998 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations EDEX alprostadil INJECTABLE;INJECTION 020649-003 Jun 12, 1997 AP RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations EDEX alprostadil INJECTABLE;INJECTION 020649-002 Jun 12, 1997 AP RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations EDEX alprostadil INJECTABLE;INJECTION 020649-005 Jul 30, 1998 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations EDEX alprostadil INJECTABLE;INJECTION 020649-004 Jun 12, 1997 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations EDEX alprostadil INJECTABLE;INJECTION 020649-006 Jul 30, 1998 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.